Kelly Schick
Human Resources Officer chez C4 THERAPEUTICS, INC.
Fortune : 573 716 $ au 29/02/2024
Profil
Presently, Kelly Schick occupies the position of Chief People Officer of C4 Therapeutics, Inc. She is also Vice President-Account Management at ScripNet LLC.
In the past she was Head-Global Talent at Bristol Myers Squibb Co. and Chief Human Resources Officer & Senior VP at AMAG Pharmaceuticals, Inc.
She received an undergraduate degree from Boston University and a graduate degree from The Curtis L.
Carlson School of Management.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
C4 THERAPEUTICS, INC.
0,08% | 07/03/2024 | 52 251 ( 0,08% ) | 573 716 $ | 29/02/2024 |
Postes actifs de Kelly Schick
Sociétés | Poste | Début |
---|---|---|
C4 THERAPEUTICS, INC. | Human Resources Officer | 12/01/2021 |
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Corporate Officer/Principal | - |
Anciens postes connus de Kelly Schick
Sociétés | Poste | Fin |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
AMAG PHARMACEUTICALS, INC. | Human Resources Officer | - |
Formation de Kelly Schick
Boston University | Undergraduate Degree |
The Curtis L. Carlson School of Management | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
C4 THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Technology Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |